Portolano Cavallo

Life Sciences

Blog

21 Nov
Certifying digital procurement platforms (PADs)
Digital procurement platforms (“PADs”) are infrastructures used by contracting authorities for digital management of procurement in accordance with the provisions of the Public Procurement Code. They are necessary for digital execution of the entire lifecycle of public contracts and are an integral part of the Italian digital procurement ecosystem (e-procurement).
20 Nov
AI and healthcare: A question of liability
Artificial intelligence (AI) systems of varying levels of sophistication are increasingly used in health care in conjunction with various medical services.
12 Jun
Digital tenders and automated procedures: New rules for public procurement
The digitization of tendering procedures is one of the most important issues addressed by the new Public Procurement Code, which systematically reorganizes and significantly changes the rules on the subject. An entire section of the code is devoted to the subject.
12 Jun
How Digital Procurement Platforms (PADs) change procurement
Among the main types of infrastructure needed to achieve full digitization of public procurement are Digital Procurement Platforms, or “PADs.” On January 1, 2024, the provisions of the new Public Procurement Code on the digitization of tender procedures became fully effective.
18 Apr
Chatbots and virtual assistants: How might they be used in pharmaceuticals?
The pharmaceutical sector is not immune to the paradigm shift in user/patient relations, connected to the development and implementation of artificial intelligence systems: when browsing the web and using smartphone applications, users increasingly encounter chatbots and virtual assistants that interact with them.
18 Jan
Doctors and the use of social media and electronic communication systems: The new FNOMCeO recommendations
FNOMCeO presented a set of Recommendations for the use of social media, e-mail, and instant messaging in the medical setting and in physician-patient communication, to prevent the potential negative repercussions of improper use of these tools.
Welcome to the Portolano Cavallo Life Sciences blog focusing on legal development and key legal issues affecting the Life Sciences-Healthcare industry.
...
Read more
Our highly-ranked team of professionals will provide news, insights and multidisciplinary commentary on the hottest and most recent regulatory, transactional and contentious aspects of the pharmaceutical, bio-tech, med-tech, food supplement and healthcare world with an eye on its digital transformation and technological developments.

This blog will be a place for focusing on digital health, telemedicine and artificial intelligence, as well as more traditional topics: from the protection of intellectual properties to performance of clinical trials, from the market access to advertising and competition issues, from internal and criminal investigations to M&A and Venture Capital transactions.

Close
October 6, 2023
CBD products: the Administrative Court suspended until October 24 the recent Decree of the Italian Ministry of Health listing cannabidiol for oral use among narcotic drugs, due to the lack o...
October 4, 2023
The Guidelines for regulating contractual relations between universities and research institutes and private sponsors were adopted by the relevant Italian Ministries following the amendment ...
September 21, 2023
CBS products: from September 20th, compositions for oral administration of cannabidiol obtained from Cannabis sativa extracts shall be considered as narcotic drugs in Italy, as they have bee...
July 27, 2023
Payback on medical devices: Italian government announces extension of payment deadline to October 30, 2023
July 21, 2023
On July 21, 2023, the Italian Ministry of Health published new guidelines on health advertising of self-medication drugs (OTC) and non-prescription drugs (SOP), including advertising on new ...
Search by...
Search
Follow us on
Follow us on